Details
Stereochemistry | ACHIRAL |
Molecular Formula | C36H62N4 |
Molecular Weight | 550.9043 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCN=C1C=CN(CCCCCCCCCCN2C=CC(C=C2)=NCCCCCCCC)C=C1
InChI
InChIKey=ZVXNYZWXUADSRV-UHFFFAOYSA-N
InChI=1S/C36H62N4/c1-3-5-7-9-15-19-27-37-35-23-31-39(32-24-35)29-21-17-13-11-12-14-18-22-30-40-33-25-36(26-34-40)38-28-20-16-10-8-6-4-2/h23-26,31-34H,3-22,27-30H2,1-2H3
Molecular Formula | C36H62N4 |
Molecular Weight | 550.9043 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Octenidine dihydrochloride is a cationic surfactant, with antimicrobial activity against Gram-positive and Gram-negative bacteria. Octenidine approved as a medicinal substance in several European countries and used for skin antisepsis in combination with aliphatic alcohols, e.g. propan-1-ol and propan-2-ol, or with detergents such as antiseptic soap. Octenidine is also used for antisepsis on wounds and mucosa either as a single substance, as an approved combination of Octenidine and phenoxyethanol. Octenidine is virtually not absorbed via the skin or mucous membranes. Because Octenidine is only approved and used topically and is virtually not absorbed, no systemic effects are to be expected. Therefore, no further pharmacokinetic studies or studies on behalf of metabolism have been conducted. Octenidine is easy and safe to handle, chemically stable, not inflammable, without resistance development and low toxicity to man and the environment alike. Its popularity among therapists and wound care specialists is based on good clinical results, easy and pain-free application and local tolerance. Beside readily available combinations with phenoxyethanol, mouth rinses, and vaginal applications, semi-fluid preparations and dressings are described.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Plasma membrane of Microorganisms Sources: https://www.ncbi.nlm.nih.gov/pubmed/28006995 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:02:21 GMT 2025
by
admin
on
Mon Mar 31 19:02:21 GMT 2025
|
Record UNII |
OZE0372S5A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
R02AA21
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
||
|
WHO-VATC |
QD08AJ57
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
||
|
WHO-ATC |
G01AX66
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
||
|
WHO-VATC |
QG01AX66
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
||
|
WHO-ATC |
D08AJ57
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3394
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
PRIMARY | |||
|
C174821
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
PRIMARY | |||
|
SUB09411MIG
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
PRIMARY | |||
|
100000083845
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
PRIMARY | |||
|
4829
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
PRIMARY | |||
|
CHEMBL1199480
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
PRIMARY | |||
|
m8113
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
PRIMARY | Merck Index | ||
|
2119240
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
PRIMARY | |||
|
51167
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
PRIMARY | |||
|
DB12624
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
PRIMARY | |||
|
OZE0372S5A
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
PRIMARY | |||
|
71251-02-0
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
PRIMARY | |||
|
DTXSID70221427
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
PRIMARY | |||
|
C034213
Created by
admin on Mon Mar 31 19:02:21 GMT 2025 , Edited by admin on Mon Mar 31 19:02:21 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |